Showing results (491-500 of 3,703) with videos related to
Sort By:
Pageof 371
Pharmacology & Therapeutics|May 23, 2006
Assessing the proarrhythmic potential of drugs: current status of models and surrogate parameters of torsades de pointes arrhythmiasMorten B Thomsen, Jørgen Matz, Paul G A Volders, et al.Pharmacology & Therapeutics|January 1, 1991
Ca2+ extrusion across plasma membrane and Ca2+ uptake by intracellular storesL Missiaen, F Wuytack, L Raeymaekers, et al.Pharmacology & Therapeutics|December 1, 1991
Phosphorothioate oligodeoxynucleotides--anti-sense inhibitors of gene expression?C A Stein, J L Tonkinson, L YakubovPharmacology & Therapeutics|January 23, 2023
Anticancer or carcinogenic? The role of estrogen receptor β in breast cancer progressionKang Shen, Huiguang Yu, Baohua Xie, et al.Pharmacology & Therapeutics|December 25, 2022
Advances in anticancer alkaloid-derived metallo-chemotherapeutic agents in the last decade: Mechanism of action and future prospectsMohammad Fawad Ansari, Huzaifa Yasir Khan, Sartaj Tabassum, et al.Pharmacology & Therapeutics|November 24, 2022
Pharmacological data science perspective on fatal incidents of morphine treatmentYazan Noufal, Dario Kringel, Stefan W Toennes, et al.Pharmacology & Therapeutics|December 8, 2022
Neutrophil extracellular traps: A novel target for the treatment of strokeZiyuan Zhao, Zirong Pan, Sen Zhang, et al.Pharmacology & Therapeutics|November 13, 2019
Therapeutic strategy for atherosclerosis based on bone-vascular axis hypothesisJeong-Min Kim, Wang-Soo Lee, Jaetaek KimPharmacology & Therapeutics|January 25, 2019
Are cell-based therapies for kidney disease safe? A systematic review of preclinical evidenceMilos Mihajlovic, Kimberley E Wever, Thom K van der Made, et al.Pharmacology & Therapeutics|July 3, 2021
New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal?Wolfgang Löscher, Pavel KleinPageof 371